Loading clinical trials...

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00413790

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

This study will evaluate the pharmacologic effects of exposure to darifenacin and tolterodine on cardiovascular parameters in healthy subjects 50 years of age and older

Lead sponsor: Novartis•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

RECRUITINGPhase 1

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866 · Healthy

RECRUITINGPhase 1

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · Healthy

RECRUITINGNA

Sodium vs Potassium Education to Improve Vascular Health

NCT07221448 · Healthy

RECRUITINGPhase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667 · Healthy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 15, 2008Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment162

Start dateNov 2006

Last updatedJan 15, 2008

Condition

Healthy

Locations shown

Investigative Site

Scottsdale, Arizona

Investigative Site

Tempe, Arizona

Investigative Site

San Diego, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 15, 2008Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Cytapheresis of Volunteer Donors

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

Sodium vs Potassium Education to Improve Vascular Health

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

Trial snapshot

Condition

Locations shown

For caregivers